Product Program year 2020 Source: CMS Open Payments

Abl002

Drug

Open in the dashboard

General payments

$118,449

47 payments

Research payments

$5,684,310

23 payments

Through program year 2020, $118,449 in general payments and $5,684,310 in research payments were reported against Abl002.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $60,766 22
2020 Research $2,215,405 12
2019 General $57,684 25
2019 Research $3,468,905 11

Breakdown

Who paid General payments · program years 2019–2020
  1. Novartis Pharmaceuticals Corporation $118,449 47 payments
Top recipients General payments · program year 2020
  1. Michael Mauro Hematology · New York, NY $9,825 16% · 3 payments
  2. Jorge Cortes-Franco Hematology & Oncology · Houston, TX $7,467 12% · 2 payments
  3. Michael Deininger Hematology · Milwaukee, WI $6,223 10% · 2 payments
  4. Richard Larson Hematology & Oncology · Chicago, IL $6,223 10% · 2 payments
  5. Hagop Kantarjian Medical Oncology · Houston, TX $4,716 8% · 1 payment

The top 5 of 17 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Hematology & Oncology Internal Medicine $35,090 58% · 12 practitioners
  2. Hematology Internal Medicine $16,048 26% · 2 practitioners
  3. Medical Oncology Internal Medicine $9,629 16% · 3 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Texas $14,063 23% · 3 recipients
  2. New York $12,445 20% · 2 recipients
  3. Illinois $6,223 10% · 1 recipient
  4. Utah $6,223 10% · 1 recipient
  5. California $5,120 8% · 2 recipients

The top 5 of 11 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

47 general · 23 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record